nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Children With Congenital Heart Disease at Elevated Risk of Depression, Anxiety, ADHD
January 26, 2021   

A recent comparative cross-sectional study was conducted to examine the risk of mental health disorders (e.g. depression, anxiety, and attention deficit/hyperactivity disorder) in youth with congenital heart disease (CHD). Data was collected from...
 Continue reading (Members only)
Ketamine Infusions May Rapidly Reduce Chronic PTSD Symptoms
January 23, 2021   

Previous research suggests that a single-dose of intravenous ketamine infusion results in significant and rapid reduction of posttraumatic stress disorder symptoms . Building on these findings, in a recent randomized controlled trial, repeated administration of ketamine infusions was tested for...
 Continue reading (Members only)
New Policy Allows Doctors Flexibility To Prescribe Buprenorphine
January 20, 2021   

The Department of Health and Human Services announced a plan to drop the X-waiver requirement for buprenorphine prescriptions. The new policy is an attempt to remove a potential barrier to opioid use disorder treatment, in which...
 Continue reading (Members only)
Genetic And Phenotypic Assessments May Inform Early Diagnoses Of Eating Disorder
January 18, 2021   

Eating disorders are common and disabling psychiatric disorders that emerge in late adolescence. The current study identified risk factors and correlates of subclinical disordered eating behaviors (DEBs) in adolescents for the purpose of informing early detection and targeted interventions. A multicenter prospective...
 Continue reading (Members only)
COVID-19 Effects in the Brain
January 14, 2021   

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as COVID-19, is associated with a host of symptoms related to the central nervous system, it is unclear if SARS-CoV-2 can penetrate the brain-blood barrier (BBB). A study by...
 Continue reading (Members only)
Identification of Suicide Attempt Risk Factors Using Machine Learning
January 8, 2021   

Machine learning methods have improved the ability to predict suicide attempt in clinical samples, particularly among high-risk patients receiving mental health treatment. However, there is a need for suicide prediction models for the general population...
 Continue reading (Members only)
Antipsychotics and the Gut Microbiome: A 2-Way Street?
December 19, 2020   

Increasingly, interest has been gathering about the role of the gut microbiome in psychiatry. The microbiome is the collection of microorganisms, such as bacteria, found in the gut and varies from one individual to the next due to a plethora of factor...
 Continue reading (Members only)
Patients With Major Depression May Experience Insulin Resistance
December 15, 2020   

Insulin resistance, the loss of response of peripheral insulin receptors to insulin, is known to be a risk factor for major depressive disorder. In this study, the authors explored the relationship of insulin resistance to the presence, severity, and chronicity of major depression in...
 Continue reading
Managing Chronic Stress, the Holidays, and the Pandemic with Dr. Jennifer Love
December 10, 2020   

How can someone tell whether they are experiencing chronic levels of stress? How has the change in the family structure affected the way that most will celebrate the holidays this year and affect the levels of chronic stress that we’re experiencing?...
 Continue reading
Bidirectional Genetic Associations Between Prescription Opioid Use And Major Depressive Disorder
December 7, 2020   

Opioid use is often comorbid with major depressive disorder and anxiety and stress-related disorders. Determining the direction and potentially causative effects of these associations would be valuable to prevention strategies. Mendelian randomization, which uses single nucleotide variants as unconfounded proxies for exposures to estimate...
 Continue reading
12345678910...
Top of Page